Kiniksa Pharmaceuticals International, plc

Ownership Transactions Reported by 14 Insiders

Symbol
KNSA on Nasdaq
Industry
Pharmaceutical Preparations
Location
23 Old Bond Street, Floor 3, London, United Kingdom

Insiders trading volume in the past year

Kiniksa Pharmaceuticals International, plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sanj K. Patel CHAIRMAN & CEO, Director $8.56M -$5.25M -38% Sep 1, 2024
Eben Tessari Chief Operating Officer $5.68M -$497K -8.04% Sep 1, 2024
John F. Paolini Chief Medical Officer $2.37M -$3.29M -58.2% Sep 1, 2024
Michael R. Megna Chief Accounting Officer $1.09M -$817K -42.9% Jul 15, 2024
Mark Ragosa Chief Financial Officer $1.05M -$841K -44.5% Sep 1, 2024
Ross Moat Chief Commercial Officer $981K -$1.79M -64.6% Jul 15, 2024
Richard S. Levy Director $231K Jun 5, 2024
G. Bradley Cole Director $168K Jun 5, 2024
Tracey L. McCain Director $168K Jun 5, 2024
Barry D. Quart Director $168K Jun 5, 2024
Kimberly J. Popovits Director $168K Jun 5, 2024
Arian Pano Chief Clinical Dev. Officer Sep 2, 2021
Baker Bros. Advisors Lp Director Jun 5, 2024
Thomas Malley Director Jun 5, 2024

Recent Insider Transactions by Companies or Individuals for Kiniksa Pharmaceuticals International, plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.